Episode 6 – Moshe Barel

Inside Medical AI: What Works, What Doesn’t, and Why It Matters

 

AI is often talked about as if it can instantly diagnose illness, replace doctors, and see everything humans miss. In healthcare, that belief can be dangerous.

In this episode of Machine Dreams, we sit down with Moshe Barel, CEO and co-founder of AccuLine, to unpack how AI is actually used in real clinical settings. Moshe has spent more than two decades in cardiovascular medicine and digital health, and his company is building a non-invasive AI-powered system for the early detection of coronary artery disease.

We talk about what AI really does inside medical diagnostics, why human-designed algorithms still matter, how regulation shapes what can safely reach patients, and why most healthcare AI is nothing like ChatGPT. From FDA approval to biased data to the myths that won’t go away, this is a grounded conversation about where AI genuinely helps, where it does not, and what it takes to build systems doctors can trust.

 

You can also listen here:

 

You can also listen here: